📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Investigating in vitro and in vivo avß6 integrin receptor-targeting liposomal alendronate for combinatory ?d T cell immunotherapy. (2017)

First Author: Hodgins NO

Attributed to: Shuttling through the Blood Brain Barrier using Carbon Nanoneedles funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2017.04.025

PubMed Identifier: 28432037

Publication URI: http://europepmc.org/abstract/MED/28432037

Type: Journal Article/Review

Volume: 256

Parent Publication: Journal of controlled release : official journal of the Controlled Release Society

ISSN: 0168-3659